Option chain shows key data for Lonza Group's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Lonza Group.

Lonza Group (OTC:LZAGF) Stock, Option Chain

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

BZ_briefs

Analyst Color

News

Health Care

Analyst Ratings

General

LZAGF

LZAGY

Lonza unveils its &#34;One Lonza&#34; strategy, highlighting a new structure to streamline operations, strengthen CDMO leadership, and project 20% CER sales growth in 2025.

Swiss Contract Service Provider Lonza Exits Capsules Business To Focus On Drug Development

Roche

Biotech

RHHBY

Lonza expands biologics manufacturing capacity with acquisition of Genentech facility in Vacaville, CA. $1.2 billion deal includes employee retention and facility upgrades. Transaction expected to boost sales growth. Closing anticipated by H2 2024.

Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche&#39;s US Facility Acquisition For $1.2B

GLPG

Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field

Lonza Group Ltd

Lonza Group

Comments

Lonza Group

Lonza Group (LZAGF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell